• DNA ploidy, Stroma Fraction and Nucleotyping as potential predictive biomarkers for adjuvant Chemotherapy of stage II Colorectal Cancer: A Multicenter Cohort Study
  AB-00116
  Sanjun Cai Presenter
• 1st line treatment strategies in BRAF-V600E mutation mCRC patients: a clinical experience and real-world data from a single center
  AB-00127
  Chiang Shih Wei Presenter
• Individualized Tumor-Informed Circulating Tumor DNA Analysis for Molecular Residual Disease Detection in Predicting Recurrence and Adjuvant Chemotherapy Efficacy in Colorectal Cancer
  AB-0061
  Di CAO Presenter
• Review of Pseudomyxoma Peritoneii Treated by Cytoreductive Surgery and Hyperthermic Intra-peritoneal Chemotherapy (CRS-HIPEC) , A Single Center Experience.
  AB-00204
  Amilah Fadhlina Binti Abd Karim Presenter
• Measurement of CD8+ T cell-mediated anti-tumor immune response induced by neoadjuvant chemo-radiation therapy using T-cell receptor analysis in rectal cancer patient
  AB-0014
  Yong Joon Lee Presenter
• Favorable long-term oncologic outcome of D3 lymph node dissection for clinical stage 2/3 right-sided colon cancer
  AB-00157
  Woong Bae Ji Presenter
• Gut Microbiota Differences Between Colorectal Cancer Patients and Healthy Individuals: A Study in Central Taiwan
  AB-00174
  YuChen Chang Presenter
• POLYREEN: A LOCALLY DEVELOPED ARTIFICIAL INTELLIGENCE SYSTEM FOR ENDOSCOPIC AUTOMATIC COLORECTAL POLYP DETECTION IN SARAWAK.
  AB-00181
  Loy Yuan Ling Presenter
• Patient-derived Organoids from BRAFV600E-Mutated Colorectal Cancer Can Capture Tumor Heterogeneity and Direct Personalized Therapy
  AB-00115
  Fangqi Liu Presenter
• Management of Malignant Rectal Polyps with Close Post-Polypectomy Margins Followed by Formal Total Mesorectal Excision – A Review of Local Experience
  AB-00136
  Gene Clyde Lim Presenter